Tower Research Capital (TRC)’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.5K Buy
9,324
+5,473
+142% +$20.9K ﹤0.01% 3266
2025
Q1
$10.1K Buy
3,851
+338
+10% +$889 ﹤0.01% 3673
2024
Q4
$12.4K Sell
3,513
-474
-12% -$1.68K ﹤0.01% 3616
2024
Q3
$18.2K Sell
3,987
-3,143
-44% -$14.3K ﹤0.01% 3289
2024
Q2
$31K Sell
7,130
-3,525
-33% -$15.3K ﹤0.01% 3466
2024
Q1
$53.5K Buy
10,655
+5,137
+93% +$25.8K ﹤0.01% 2228
2023
Q4
$34.6K Sell
5,518
-6,472
-54% -$40.6K ﹤0.01% 3346
2023
Q3
$85.4K Buy
11,990
+11,285
+1,601% +$80.3K ﹤0.01% 2095
2023
Q2
$7.18K Sell
705
-16,277
-96% -$166K ﹤0.01% 4587
2023
Q1
$154K Buy
16,982
+2,533
+18% +$23K ﹤0.01% 1520
2022
Q4
$104K Buy
14,449
+6,433
+80% +$46.3K ﹤0.01% 1810
2022
Q3
$52K Buy
8,016
+1,520
+23% +$9.86K ﹤0.01% 3135
2022
Q2
$31K Buy
6,496
+6,396
+6,396% +$30.5K ﹤0.01% 3350
2022
Q1
$1K Buy
+100
New +$1K ﹤0.01% 5851
2021
Q3
Sell
-2,112
Closed -$13K 6124
2021
Q2
$13K Sell
2,112
-621
-23% -$3.82K ﹤0.01% 4235
2021
Q1
$18K Sell
2,733
-807
-23% -$5.32K ﹤0.01% 3968
2020
Q4
$19K Sell
3,540
-2,015
-36% -$10.8K ﹤0.01% 3905
2020
Q3
$41K Sell
5,555
-5,685
-51% -$42K ﹤0.01% 3619
2020
Q2
$83K Buy
11,240
+9,639
+602% +$71.2K ﹤0.01% 2627
2020
Q1
$12K Buy
1,601
+964
+151% +$7.23K ﹤0.01% 1946
2019
Q4
$4K Buy
+637
New +$4K ﹤0.01% 2815
2019
Q3
Sell
-3,211
Closed -$10K 4471
2019
Q2
$10K Sell
3,211
-4,235
-57% -$13.2K ﹤0.01% 2576
2019
Q1
$22K Buy
7,446
+6,420
+626% +$19K ﹤0.01% 2221
2018
Q4
$4K Buy
1,026
+751
+273% +$2.93K ﹤0.01% 3064
2018
Q3
$2K Sell
275
-1,155
-81% -$8.4K ﹤0.01% 3475
2018
Q2
$8K Buy
+1,430
New +$8K ﹤0.01% 2891